The US Food and Drug Administration approved FDAOn a new HIV injection called Sunlinka Sunlenca an injectable treatment to suppress HIV, for patients with drug-resistant other systems.
Experts stressed that the new injections, which work in lower doses in the number of times they are taken, which might be a game-changer for those who do not respond to other treatments..
According to the site Medical ExpressThis drug was developed by Gilead Gilead Sciences It is the first in a new class called capsid inhibitors, which work by blocking the protein envelope or preventing virus replication and reducing viral load, which leads to disruption of multiple stages of the virus life cycle, explaining that in the clinical trial, 83% of patients who took Injections Sunlenca With a combination of other drugs a small viral load is undetectable following regarding a year.
What is Sunlenca’s HIV treatment?
Sunlenca or lenacapavir It is the first in a new class of drugs approved by the US Food and Drug Administration. FDA“to treat HIV” AIDS“.
The site added that the drug linacabavir Lenacapavir Sunlinka is an antiretroviral drug that works by preventing the virus from multiplying to keep HIV levels in the body very low..
Sunlinka approved Sunlenca For patients infected with the human immunodeficiency virus “AIDS” whose infection did not respond to other multiple treatment regimens, treatment begins with a system of oral tablets and injections, then continuous injections every 6 months..